BioGotec Ltd. The company was established by 3 highly experienced pharma executives who have all enjoyed the experience of start-up companies and want to utilize their collective expertise to assist small to medium sized pharma companies who wish to access the European market with their drugs or devices. Each Director has a proven track record of successful launches of high-end pharma products in Europe. The team focuses primarily on supporting companies with novel, niche, high value products for unmet needs to strategically evaluate all options for entering the European market place. This can vary from setting up a commercial operation to supply patients in Europe to performing market access projects to inform re partnering and supplying EU market access knowledge to empower negotiations. This can lead onto, if required, strategic and tactical planning and even implementation of launches to result in market entry of products quickly, cost-effectively and successfully. The team utilises their past experience and collective expertise to accommodate the resources of their customers resulting in “fit for purpose” planning. Whether it is an Orphan Drug, a product for a rare disease, a new formulation or a novel device our aim is to become the recognised start-up specialists for small to mid-sized pharma and device companies planning their entry to Europe.